litlas
ログインアカウント作成

Marc C. Chamberlain

1988–2025 年に発表

111
論文数
21,726
被引用数
85
h 指数
110
i10 指数

被引用数

Marc C. Chamberlain の年別被引用数1984 年: 被引用 1 件1986 年: 被引用 1 件1989 年: 被引用 1 件1990 年: 被引用 3 件1992 年: 被引用 1 件1993 年: 被引用 14 件1994 年: 被引用 2 件1995 年: 被引用 10 件1996 年: 被引用 13 件1997 年: 被引用 17 件1998 年: 被引用 42 件1999 年: 被引用 20 件2000 年: 被引用 30 件2001 年: 被引用 17 件2002 年: 被引用 32 件2003 年: 被引用 27 件2004 年: 被引用 39 件2005 年: 被引用 77 件2006 年: 被引用 69 件2007 年: 被引用 36 件2008 年: 被引用 67 件2009 年: 被引用 98 件2010 年: 被引用 168 件2011 年: 被引用 211 件2012 年: 被引用 171 件2013 年: 被引用 204 件2014 年: 被引用 202 件2015 年: 被引用 185 件2016 年: 被引用 192 件2017 年: 被引用 226 件2018 年: 被引用 200 件2019 年: 被引用 689 件2020 年: 被引用 757 件2021 年: 被引用 590 件2022 年: 被引用 528 件2023 年: 被引用 386 件2024 年: 被引用 545 件2025 年: 被引用 236 件2026 年: 被引用 6 件1985 年は被引用が無いため表示していません1987〜1988 年は被引用が無いため表示していません1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,084 件、この内訳の 28.3%ドイツ: 引用元論文 629 件、この内訳の 8.5%中国: 引用元論文 483 件、この内訳の 6.5%イタリア: 引用元論文 448 件、この内訳の 6.1%イギリス: 引用元論文 388 件、この内訳の 5.3%フランス: 引用元論文 364 件、この内訳の 4.9%オランダ: 引用元論文 317 件、この内訳の 4.3%スイス: 引用元論文 288 件、この内訳の 3.9%カナダ: 引用元論文 257 件、この内訳の 3.5%スペイン: 引用元論文 179 件、この内訳の 2.4%オーストリア: 引用元論文 154 件、この内訳の 2.1%日本: 引用元論文 153 件、この内訳の 2.1%
0%28.3%その他 22.1%

機関

分野

  • Medicine80.8%
  • Biochemistry, Genetics and Molecular Biology9.3%
  • Materials Science3%
  • Neuroscience2.4%
  • Engineering1.1%
  • Immunology and Microbiology1.1%
  • その他2.3%

トピック

  • Glioma Diagnosis and Treatment20%
  • Brain Metastases and Treatment10.3%
  • Meningioma and schwannoma management4.8%
  • Radiomics and Machine Learning in Medical Imaging3.3%
  • Lung Cancer Research Studies2.6%
  • MRI in cancer diagnosis2.3%
  • その他56.7%

共著者

全論文

検索で開く
  1. Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

    著者: Patrick Y. Wen, David R. Macdonald, David A. Reardon, Timothy F. Cloughesy, A. Gregory Sorensen, Evanthia Galanis, John DeGroot, Wolfgang Wick, Mark R. Gilbert, Andrew B. Lassman, Christina Tsien, Tom Mikkelsen, Eric T. Wong, Marc C. Chamberlain, Roger Stupp, Kathleen R. Lamborn, Michael A. Vogelbaum, Martin J. van den Bent, Susan M. Chang - Journal of Clinical Oncology 2010 被引用: 3,829

  2. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas

    著者: Martin J. van den Bent, JS Wefel, David Schiff, M. J. B. Taphoorn, Kurt A. Jaeckle, Larry Junck, Terri S. Armstrong, Ali Choucair, Adam Waldman, Thierry Gorlia, Marc C. Chamberlain, BG Baumert, MA Vogelbaum, DR Macdonald, DA Reardon, PY Wen, SM Chang, AH Jacobs - The Lancet Oncology 2011 被引用: 645

  3. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas

    著者: Nathalie L. Albert, Michael Weller, Bogdana Suchorska, Norbert Galldiks, Riccardo Soffietti, Michelle M. Kim, Christian la Fougère, Whitney B. Pope, Ian Law, Javier Arbizu, Marc C. Chamberlain, Michael A. Vogelbaum, Ben M. Ellingson, J. C. Tonn - Neuro-Oncology 2016 被引用: 745

  4. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review

    著者: Leland Rogers, Igor J. Barani, Marc C. Chamberlain, Thomas Kaley, Michael McDermott, Jeffrey Raizer, David Schiff, Damien C. Weber, Patrick Y. Wen, Michael A. Vogelbaum - Journal of neurosurgery 2014 被引用: 696

  5. Leptomeningeal metastases: a RANO proposal for response criteria

    著者: Marc C. Chamberlain, Larry Junck, Dieta Brandsma, Riccardo Soffietti, Roberta Rudà, Jeffrey J. Raizer, Willem Boogerd, Sophie Taillibert, Morris D. Groves, Émilie Le Rhun, Julie Walker, Martin J. van den Bent, Patrick Y. Wen, Kurt A. Jaeckle - Neuro-Oncology 2016 被引用: 319

  6. The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria

    著者: Lakshmi Nayak, Lisa M. DeAngelis, Alba A. Brandes, David M. Peereboom, Evanthia Galanis, Nancy U. Lin, Riccardo Soffietti, David R. Macdonald, Marc C. Chamberlain, James Perry, Kurt A. Jaeckle, Minesh P. Mehta, Roger Stupp, Alona Muzikansky, Elena Pentsova, Timothy F. Cloughesy, Fábio M. Iwamoto, J. C. Tonn, Michael A. Vogelbaum, Patrick Y. Wen, Martin J. van den Bent, David A. Reardon - Neuro-Oncology 2017 被引用: 244

  7. Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer

    著者: Virginia F. Borges, Cristiano Ferrario, Nathalie Aucoin, Carla I. Falkson, Qamar J. Khan, Ian E. Krop, Stephen Welch, Alison Conlin, Jorge Chaves, Philippe L. Bédard, Marc C. Chamberlain, Todd Gray, Alex Vo, Erika Hamilton - JAMA Oncology 2018 被引用: 165

  8. Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma

    著者: Wolfgang Wick, Vinay K. Puduvalli, Marc C. Chamberlain, Martin J. van den Bent, Alain Carpentier, Lawrence Cher, Warren Mason, Michael Weller, Shengyan Hong, Luna Musib, Astra M. Liepa, Donald Thornton, Howard A. Fine - Journal of Clinical Oncology 2010 被引用: 514

  9. A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma

    著者: Kathryn E. Beckermann, Amita Patnaik, Ira Winer, Winston Tan, Babar Bashir, Christos E. Kyriakopoulos, Randy F. Sweis, Marc C. Chamberlain, Brian I. Rini - Investigational New Drugs 2024 被引用: 30

  10. PET imaging in patients with brain metastasis—report of the RANO/PET group

    著者: Norbert Galldiks, Karl‐Josef Langen, Nathalie L. Albert, Marc C. Chamberlain, Riccardo Soffietti, Michelle M. Kim, Ian Law, Émilie Le Rhun, Susan M. Chang, Julian Schwarting, Stephanie E. Combs, Matthias Preusser, Peter Forsyth, Whitney B. Pope, Michael Weller, Jörg C. Tonn - Neuro-Oncology 2019 被引用: 194

  11. Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study

    著者: Grant A. McArthur, Michele Maio, Ana Arance, Paul Nathan, Christian U. Blank, Marie‐Françoise Avril, Claus Garbe, Axel Hauschild, Dirk Schadendorf, Omid Hamid, Michael Fluck, Melissa S. Thebeau, Jacob Schachter, Richard Kefford, Marc C. Chamberlain, Martina Makrutzki, Susan Robson, René González, Kim Margolin - Annals of Oncology 2016 被引用: 246

  12. Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee

    著者: Katherine E. Warren, Gilbert Vézina, Tina Young Poussaint, Monika Warmuth‐Metz, Marc C. Chamberlain, Roger J. Packer, Alba A. Brandes, Moshe Reiss, Stewart Goldman, Michael J. Fisher, Ian F. Pollack, Michael D. Prados, Patrick Y. Wen, Susan M. Chang, Christelle Dufour, David Zurakowski, Rolf D. Kortmann, Mark W. Kieran - Neuro-Oncology 2017 被引用: 128

  13. Systemic therapy of brain metastases: non–small cell lung cancer, breast cancer, and melanoma

    著者: Marc C. Chamberlain, Christina S. Baik, Vijayakrishna K. Gadi, Shailender Bhatia, Laura Q.M. Chow - Neuro-Oncology 2016 被引用: 223

  14. Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials

    著者: Edward K. Avila, Marc C. Chamberlain, David Schiff, Jaap C. Reijneveld, Terri S. Armstrong, Roberta Rudà, Patrick Y. Wen, Michael Weller, Johan A F Koekkoek, Sandeep Mittal, Yoshiki Arakawa, Ali Choucair, Jorge González-Martínez, David Macdonald, Ryo Nishikawa, Aashit Shah, Charles J. Vecht, Paula Warren, Martin J. van den Bent, Lisa M. DeAngelis - Neuro-Oncology 2016 被引用: 128

  15. Chemotherapy-Related Neurotoxicity

    著者: Sophie Taillibert, Émilie Le Rhun, Marc C. Chamberlain - Current Neurology and Neuroscience Reports 2016 被引用: 122

  16. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.

    著者: Michael Glantz, Kurt A. Jaeckle, Marc C. Chamberlain, Surasak Phuphanich, Lawrence D. Recht, L. J. Swinnen, B Maria, S LaFollette, Günter Schumann, Bernard F. Cole, Stephen B. Howell - 1999 被引用: 528

  17. Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy

    著者: Patrick Y. Wen, Jan Drappatz, John de Groot, Michael D. Prados, David A. Reardon, David Schiff, Marc C. Chamberlain, Tom Mikkelsen, Annick Desjardins, Jaymes Holland, Jerry Ping, Ron Weitzman, Timothy F. Cloughesy - Neuro-Oncology 2017 被引用: 116

  18. A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients

    著者: Brain Tumor Trials Collaborative, Jeffrey J. Raizer, Pierre Giglio, Jethro Hu, Mari L. Groves, Ryan Merrell, C. Conrad, Surasak Phuphanich, Vinay K. Puduvalli, Monica Loghin, Nina A. Paleologos, Ying Yuan, D. Liu, Alfred Rademaker, W.K. Alfred Yung, Brian Vaillant, Jeremy Rudnick, Marc C. Chamberlain, Nicholas A. Vick, Sean Grimm, Ivo W. Tremont‐Lukats, John de Groot, Kenneth Aldape, Mark R. Gilbert - Journal of Neuro-Oncology 2015 被引用: 81

  19. A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma

    著者: Vinay K. Puduvalli, Jing Wu, Ying Yuan, Terri S. Armstrong, Elizabeth Vera, Jimin Wu, Jihong Xu, Pierre Giglio, Howard Colman, Tobias Walbert, Jeffrey J. Raizer, Morris D. Groves, David Tran, Fábio M. Iwamoto, Nicholas G. Avgeropoulos, Nina A. Paleologos, Karen Fink, David M. Peereboom, Marc C. Chamberlain, Ryan Merrell, Marta Penas Prado, W.K. Alfred Yung, Mark R. Gilbert - Neuro-Oncology 2020 被引用: 46

  20. Adult Primary Intradural Spinal Cord Tumors: A Review

    著者: Marc C. Chamberlain, Trent L. Tredway - Current Neurology and Neuroscience Reports 2011 被引用: 338

  21. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas

    著者: Marc C. Chamberlain - Expert Review of Neurotherapeutics 2010 被引用: 188

  22. Central Nervous System Cancers, Version 1.2015

    著者: Burt Nabors, Jana Portnow, Mario Ammirati, Joachim M. Baehring, Henry Brem, Paul D. Brown, Nicholas Butowski, Marc C. Chamberlain, Robert A. Fenstermaker, Allan H. Friedman, Mark R. Gilbert, Jona A. Hattangadi‐Gluth, Matthias Holdhoff, Larry Junck, Thomas Kaley, Ronald Lawson, Jay S. Loeffler, Mary Lovely, Paul L. Moots, Maciej M. Mrugała, Herbert B. Newton, Ian F. Parney, Jeffrey J. Raizer, Lawrence D. Recht, Nicole Shonka, Dennis C. Shrieve, Allen K. Sills, Lode J. Swinnen, David Tran, Nam Tran, Frank D. Vrionis, Stephanie E. Weiss, Patrick Y. Wen, Nicole R. McMillian, Anita M. Engh - Journal of the National Comprehensive Cancer Network 2015 被引用: 178

  23. Gender disparity in the rate of partner abandonment in patients with serious medical illness

    著者: Michael Glantz, Marc C. Chamberlain, Qin Liu, Chung‐Cheng Hsieh, Keith R. Edwards, Alixis Van Horn, Lawrence D. Recht - Cancer 2009 被引用: 144

  24. A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma

    著者: Priya Kumthekar, Sean Grimm, Roxanne T Aleman, Marc C. Chamberlain, David Schiff, Patrick Y. Wen, Fábio M. Iwamoto, Demirkan Gursel, David A. Reardon, Benjamin Purow, Masha Kocherginski, Irene Helenowski, Jeffrey J. Raizer - Neuro-Oncology Advances 2022 被引用: 37